Section II
5221 – 5230 of 8614
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Pseudomonas aeruginosa in cystic fibrosis: Pyocyanin negative strains are associated with BPI-ANCA and progressive lung disease.
(
- Contribution to journal › Article
-
Mark
Insights from the evidence evaluation process - Do we have the answers for therapeutic hypothermia?
(
- Contribution to journal › Letter
-
Mark
Pain still hurts: can we do better for our patients?
(
- Contribution to journal › Article
-
Mark
TWENTY YEARS OF HUMAN RESEARCH ETHICS COMMITTEES IN THE BALTIC STATES.
(
- Contribution to journal › Article
-
Mark
Physiological functions and clinical implications of sphingolipids in the gut.
(
- Contribution to journal › Article
-
Mark
Scandinavian glutamine trial: a pragmatic multi-centre randomised clinical trial of intensive care unit patients.
(
- Contribution to journal › Article
-
Mark
Intimal Hyperplasia in Balloon Dilated Coronary Arteries is Reduced by Local Delivery of the NO Donor, SIN-1 Via a cGMP-Dependent Pathway.
(
- Contribution to journal › Article
-
Mark
Tracing neural connections to pain pathways with relevance to primary headaches.
(
- Contribution to journal › Article
-
Mark
Biochemical diagnosis of primary hyperparathyroidism: Analysis of the sensitivity of total and ionized calcium in combination with PTH.
(
- Contribution to journal › Article
-
Mark
Reply to the letter by P. Guillausseau Regarding "Sulfonylureas or Dipeptidyl Peptidase (DPP-4) Inhibitors in the Management of Type 2 Diabetes: Debate Is Not Yet Closed"
(
- Contribution to journal › Article